Director, Lahey Integrated Heart Failure Network
Cardiology
Dr. Richard D. Patten, MD
|
|
Give Review
Richard Patten practices Cardiology. He studied medicine at University of Maryland School of Medicine. University of Maryland School of Medicine is ranked 37 in research and 52 in primary care medicine He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Doctor Richard D. Patten, MD is a published doctor and has 42 publications published. The lastest was: 'Ventricular remodeling and its prevention in the treatment of heart failure.' Doctor Richard D. Patten, MD is registered with Medicare.
Publications
- Decreased Metalloprotease 9 Induction, Cardiac Fibrosis and Higher Autophagy after Pressure Overload in Mice Lacking the Transcriptional Regulator p8.
- Deficiency of the transcriptional regulator p8 results in increased autophagy and apoptosis, and causes impaired Heart function.
- Virtual histology intravascular ultrasound assessing the risk of Cardiac allograft vasculopathy.
- Small animal models of Heart failure: development of novel therapies, past and present.
- Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
- The effect of ventricular assist devices on post-transplant mortality an analysis of the United network for organ sharing thoracic registry.
- Influence of donor cocaine use on outcome after Cardiac transplantation: analysis of the United Network for Organ Sharing Thoracic Registry.
- Increased FOG-2 in failing myocardium disrupts thyroid hormone-dependent SERCA2 gene transcription.
- 17 Beta-estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following Myocardial infarction and pressure overload.
- Parasympathetic response in chick myocytes and mouse Heart is controlled by SREBP.
- Age-related changes in echocardiographic measurements: association with variation in the estrogen receptor-alpha gene.
- Helix-loop-helix protein p8, a transcriptional regulator required for cardiomyocyte hypertrophy and Cardiac fibroblast matrix metalloprotease induction.
- Models of Gender Differences in Cardiovascular Disease.
- Gene 33/RALT is induced by hypoxia in cardiomyocytes, where it promotes cell death by suppressing phosphatidylinositol 3-kinase and extracellular signal-regulated kina...
- Estrogen replacement and cardiomyocyte protection.
- Gender-specific patterns of left ventricular and myocyte remodeling following Myocardial infarction in mice deficient in the angiotensin II type 1a receptor.
- Ventricular assist device therapy normalizes inducible nitric oxide synthase expression and reduces cardiomyocyte apoptosis in the failing human Heart.
- Current Treatment Options for CHF Management: Focus on the Renin-Angiotensin-Aldosterone System.
- 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling.
- Prevention and Reversal of LV Remodeling with Neurohormonal Inhibitors.
- 17-beta-estradiol increases Cardiac remodeling and mortality in mice with myocardial infarction.
- New concepts in post-Infarction ventricular remodeling.
- Use of pulse wave and color flow Doppler echocardiography in mouse models of human Disease.
- Isolated rupture of the cisterna chyli after blunt trauma.
- Thin-filament-based modulation of contractile performance in human Heart failure.
- Design of a phase 1/2 trial of intraCoronary administration of AAV1/SERCA2a in patients with heart failure.
- Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.
- Glycogen synthase kinase-3beta regulates growth, calcium homeostasis, and diastolic function in the Heart.
- Deletion of cytosolic phospholipase A2 promotes striated muscle growth.
- Calcium channel blockers in Heart failure: help or hindrance?
- Causes of death and rehospitalization in patients hospitalized with worsening Heart failure and reduced left ventricular ejection fraction: results from Efficacy of Va...
- The CREB leucine zipper regulates CREB phosphorylation, Cardiomyopathy, and lethality in a transgenic model of heart failure.
- The beta-catenin/T-cell factor/lymphocyte enhancer factor signaling pathway is required for normal and stress-induced Cardiac hypertrophy.
- Effects of losartan and captopril on left ventricular volumes in elderly patients with Heart failure: results of the ELITE ventricular function substudy.
- Ventricular remodeling and its prevention in the treatment of Heart failure.
- Ventricular remodeling in a mouse model of Myocardial infarction.
- Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on Myocardial cellular proliferation and collagen deposition after...
- Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ven...
- Effects of intraVenous magnesium sulfate on arrhythmias in patients with congestive heart failure.
- Beneficial effects of metoprolol in heart failure associated with Coronary artery disease: a randomized trial.
- Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following Myocardial infarction in the mouse.
Schools
University Of Maryland School Of Medicine
University Of Maryland
Colby College
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Acute Venous Embolism Thrombosis
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
Tufts Medical Center -
University of Maryland -
University of Maryland School of Medicine
Hospital
-
Lahey Hospital & Medical Center, Burlington
Drug Facts
| NPI NUMBER | 1992813042 | |
| NPPES Provider LastName | PATTEN | |
| NPPES Provider FirstName | RICHARD | |
| NPPES Provider ZIPCode | 018050001 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 2922.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1992813042 |
| Last Name Of The Provider | PATTEN |
| First Name Of The Provider | RICHARD |
| View All |
Similar Doctors
|
Dr. David T. Martin, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Maurizio Diaco, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard W. Nesto, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Roberto C. Ugarte, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arjun R. Majithia, MD |
|
|
Dr. Lauren G. Gilstrap, MD |
|
|
Dr. John Kelly, MD |
|
|
Dr. Gautam Gadey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory F. Michaud, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|